Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Stock Price Up 0.1% – Here’s Why

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) shot up 0.1% during mid-day trading on Friday . The company traded as high as $25.39 and last traded at $25.35. 531 shares traded hands during trading, a decline of 89% from the average session volume of 5,051 shares. The stock had previously closed at $25.33.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Price Performance

The business’s fifty day simple moving average is $25.27 and its two-hundred day simple moving average is $25.35.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th were issued a dividend of $0.5391 per share. This represents a $2.16 annualized dividend and a yield of 8.51%. This is an increase from Harrow Health, Inc. 8.625% Senior Notes due 2026’s previous quarterly dividend of $0.54. The ex-dividend date was Wednesday, January 15th.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.